Bloodloss study after Aortic valve replacement Impact of Mecc perfusion vs conventional ECCperfusion

Bloodloss study after Aortic valve replacement Impact of Mecc perfusion vs conventional ECCperfusion - Bloodloss study after Aortic valve replacement

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON39590

Enrollment

310

Registered

2012-04-05

Start date

2012-06-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bloodloss BloodTransfusion

Interventions

Elective Aortic valve replacement

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Elective indicated AVR procedures

Exclusion criteria

Exclusion criteria: Redo Hartsurgery

Design outcomes

Primary

Measure	Time frame
Lab;C-reactief proteïne, leukocyten, platelets, hemoglobine, hematocriet, creatinine, ureum, glomerular filtration fate**, CK, CKMB, troponine en myoglobine Bloodloss through Thoracicdrains Amount of bloodtransfusion units	—

Secondary

Measure	Time frame
Length of stay on ICU Re-interventions like Re-operatins as a Re-Sternotomia	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)